Epidemiology of infection with Epstein-Barr virus types 1 and 2: Lessons from the study of a T-cell-immunocompromised hemophilic cohort

被引:43
作者
Yao, QY
Croom-Carter, DSG
Tierney, RJ
Habeshaw, G
Wilde, JT
Hill, FGH
Conlon, C
Rickinson, AB [1 ]
机构
[1] Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England
[2] Univ Hosp Trust, Dept Haematol, Birmingham B15 2TH, W Midlands, England
[3] Childrens Hosp, Dept Haematol, Birmingham B16 8ET, W Midlands, England
[4] John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England
关键词
D O I
10.1128/JVI.72.5.4352-4363.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In apparent contrast to earlier work on Epstein Barr virus (EBV) carriage in the general Caucasian population, in vitro virus isolations from human immunodeficiency virus (HIV)-positive male homosexual cohorts have shown frequent examples of multiple EBV infection and an overall prevalence of type 2 EBV strains exceeding 30%, Here we ask to what extent these findings might hold true in another T-cell-immunocompromised cohort, HIV-positive hemophilic patients. Resident EBV strains were rescued within lymphoblastoid cell lines derived from the blood and throat washings of 39 such individuals, using the same in vitro protocols of virus isolation as for the homosexual cohort. A mean of 19 independent cell lines was made per patient, and in each case the resident virus was characterized by PCR-based viral genomic analysis and by immunoblotting to reveal the viral "EBNAprint." By these criteria a significant proportion (14 of 39) of the hemophilic cohort carried more than one EBV strain, suggesting that T-cell impairment does indeed sensitize virus carriers to reinfection with new strains of exogenously transmitted virus. However, the overall incidence of type 2 EBV infection was 10%, which is close to that observed in the earlier work with healthy carriers and substantially lower than that seen in HIV-positive homosexuals. We infer that type 2 EBV is relatively rare in the general Caucasian population but has become endemic in the homosexual community.
引用
收藏
页码:4352 / 4363
页数:12
相关论文
共 62 条
[41]   INFLUENCE OF THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN EBNA 2 ON THE GROWTH PHENOTYPE OF VIRUS-TRANSFORMED B-CELLS [J].
RICKINSON, AB ;
YOUNG, LS ;
ROWE, M .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1310-1317
[42]   DISTINCTION BETWEEN EPSTEIN-BARR VIRUS TYPE-A (EBNA-2A) AND TYPE-B (EBNA-2B) ISOLATES EXTENDS TO THE EBNA-3 FAMILY OF NUCLEAR PROTEINS [J].
ROWE, M ;
YOUNG, LS ;
CADWALLADER, K ;
PETTI, L ;
KIEFF, E ;
RICKINSON, AB .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1031-1039
[43]   MONOCLONAL-ANTIBODIES TO THE LATENT MEMBRANE-PROTEIN OF EPSTEIN-BARR-VIRUS REVEAL HETEROGENEITY OF THE PROTEIN AND INDUCIBLE EXPRESSION IN VIRUS-TRANSFORMED CELLS [J].
ROWE, M ;
EVANS, HS ;
YOUNG, LS ;
HENNESSY, K ;
KIEFF, E ;
RICKINSON, AB .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :1575-1586
[44]   EPSTEIN-BARR-VIRUS TYPE-1 AND TYPE-2 DIFFER IN THEIR EBNA-3A, EBNA-3B, AND EBNA-3C GENES [J].
SAMPLE, J ;
YOUNG, L ;
MARTIN, B ;
CHATMAN, T ;
KIEFF, E ;
RICKINSON, A ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4084-4092
[45]   IDENTIFICATION OF POTENTIAL HOT-SPOTS IN THE CARBOXY-TERMINAL PART OF THE EPSTEIN-BARR-VIRUS (EBV) BNLF-1 GENE IN BOTH MALIGNANT AND BENIGN EBV-ASSOCIATED DISEASES - HIGH-FREQUENCY OF A 30-BP DELETION IN MALAYSIAN AND DANISH PERIPHERAL T-CELL LYMPHOMAS [J].
SANDVEJ, K ;
PEH, SC ;
ANDRESEN, BS ;
PALLESEN, G .
BLOOD, 1994, 84 (12) :4053-4060
[46]   Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-Associated disorders [J].
Schuster, V ;
Ott, G ;
Seidenspinner, S ;
Kreth, HW .
BLOOD, 1996, 87 (04) :1579-1585
[47]   COINFECTION WITH A-TYPE AND B-TYPE EPSTEIN-BARR-VIRUS IN HUMAN-IMMUNODEFICIENCY-VIRUS POSITIVE SUBJECTS [J].
SCULLEY, TB ;
APOLLONI, A ;
HURREN, L ;
MOSS, DJ ;
COOPER, DA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (03) :643-648
[48]   EXPRESSION OF EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN-3, ANTIGEN-4, AND ANTIGEN-6 ARE ALTERED IN CELL-LINES CONTAINING B-TYPE VIRUS [J].
SCULLEY, TB ;
APOLLONI, A ;
STUMM, R ;
MOSS, DJ ;
MUELLERLANTCZH, N ;
MISKO, IS ;
COOPER, DA .
VIROLOGY, 1989, 171 (02) :401-408
[49]  
SHIBATA D, 1993, BLOOD, V81, P2102
[50]  
SIXBEY JW, 1989, LANCET, V2, P761